Toggle light / dark theme

A very simple reason why whether or not people want to live ‘forever’ doesn’t matter in the discussion about rejuvenation biotechnologies, plus a couple of thought experiments to better understand the wish to ‘die at some point’ of some.


You don’t want to live forever? Then don’t.

I’m not kidding. It is as simple as that, and I’ll tell you more. If you—or even the entire world, for that matter—don’t want to live forever, it doesn’t mean we shouldn’t develop rejuvenation therapies.

Why? Because rejuvenation therapies do not make you immortal. Being forever young only means you don’t get age-related diseases and disabilities, not that you can’t be shot or run over by a truck, or that you can’t kill yourself. On top of that, you don’t have to undergo rejuvenation therapies if you don’t want to. However, while rejuvenation wouldn’t make you immortal, it would give you more control over you life. If you say you know for a fact you want to die at some point, I’m cool with that, but there is no guarantee ageing will kill you just at the right moment. Ageing could easily take you away when you still had tons of things you wanted to do. On the other hand, if you didn’t have to worry about the possibility of such an untimely death, you could very well decide for yourself when and how you want to go, and be relatively sure it’d happen that way.

Read more

Here’s a write-up of Moogfest that has a section dedicated to the Immortality Bus and transhumanism:


The ExitEvent team is all hands on deck for the next four days as we try to capture all the cool stuff going on in downtown Durham for Moogfest. We’ll post photos, videos, stories and soundbites as we get them. Feel free to submit your own captures as well!

Thanks for following along!

(photo above, credit to Moogfest)

Read more

Still, the seed vault is supposed to function without humans having to get involved with maintenance. The Norwegian government is studying the situation and plans to fix the leak.


It was a story that was too good to pass up. The Svalbard ‘doomsday’ seed vault had flooded because of global warming-induced high temperatures melting the surrounding permafrost. But according to one of the vault’s creators, the reports are pretty overblown and everything’s fine. Well, the vault’s fine. The apocalypse is still ticking along nicely.

Read more

I’m talking #transhumanism, liberty, the Immortality Bus, politics, and overcoming death w/ science. I’ll be making a tribute to my recently deceased father too. There will be a Q & A after. http://sched.co/AGbE & https://moogfest2017.sched.com/artist/info6094

Read more

My event starts at 4:30PM and is at: Carolina Theatre, Cinema 1 309 W Morgan St, Durham, NC 27701 The Immortality Bus, despite controversy and resistance from some transhumanists, defied many odds and has become one of the widely discussed pieces of art and events in the futurist world. Come watch never before seen slides on how the bus, science activism, and my presidential campaign made its way across America and delivered the Transhumanist Bill of Rights to the US Capitol. http://sched.co/AGbE & https://moogfest2017.sched.com/artist/info6094

Read more

My Immortality Bus trip and transhumanist presidential campaign is the subject of the first chapter (40 pages long). Grab a copy of this excellent book and read about radical personalities attempting to change the world: https://www.amazon.co.uk/Radicals-Jamie-Bartlett-ebook/dp/B01K6ROZPC/ref=tmm_kin_swatch_0?_encoding=UTF8&qid=1488876454&sr=8-1

Read more

CellAge, the synthetic biology company are going from strength to strength thanks to the support of the community last year during their fundraiser at Lifespan.io.


CellAge is featured in Startup Lithuania. As many of you will recall, CellAge hosted a successful project with us at Lifespan.io and they are busy developing a new aging biomarker for researchers thanks to the support of the community.

Now they are going from strength to strength having just secured a seed round backed by Michael Greve’s Kizoo Technology Capital and other investors.

Read more